That trial (announced in 2023) is the first to prove that treating obesity pharmacologically can prevent cardiovascular events , a groundbreaking concept
Whilst mild to moderate gastrointestinal symptoms are expected with Ozempic therapy, certain presentations warrant prompt medical assessment to exclude serious complications or conditions requiring intervention
If you havent found respite from your symptoms with other methods or traditional treatments, call me to book a consultation, and lets discuss all the other options you may not have heard of
Semaglutide belongs in a class called GLP-1 receptor agonists, which help regulate appetite and blood sugar in different ways than insulin does
This two-second verification has prevented countless dosing errors
their uses, benefits and risks with the hope of helping you decide whether or not this option is a good one for you